These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1423160)

  • 1. Are too many children being treated with methylphenidate?
    Ruel JM; Hickey CP
    Can J Psychiatry; 1992 Oct; 37(8):570-2. PubMed ID: 1423160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Methylphenidate--current prescribing rate].
    Elliger TJ
    Z Kinder Jugendpsychiatr; 1991 Dec; 19(4):268-70. PubMed ID: 1812677
    [No Abstract]   [Full Text] [Related]  

  • 3. Ritalin use in BC.
    Rees A
    CMAJ; 2000 Mar; 162(6):753-4. PubMed ID: 10750449
    [No Abstract]   [Full Text] [Related]  

  • 4. Psychostimulants and psychiatrists: the Trent Adult Psychiatry Psychostimulant Survey.
    Bramble D
    J Psychopharmacol; 2000 Mar; 14(1):67-9. PubMed ID: 10757256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prescription of methylphenidate to children and youth, 1990-1996.
    Miller AR; Lalonde CE; McGrail KM; Armstrong RW
    CMAJ; 2001 Nov; 165(11):1489-94. PubMed ID: 11762572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in the prescribing of stimulant medication for the treatment of Attention Deficit Hyperactivity Disorder in adults in New South Wales.
    New South Wales Department of Health
    N S W Public Health Bull; 2004; 15 Suppl 3():1-55. PubMed ID: 15448720
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical response to methylphenidate in children diagnosed with attention-deficit hyperactivity disorder and comorbid psychiatric disorders.
    Ter-Stepanian M; Grizenko N; Zappitelli M; Joober R
    Can J Psychiatry; 2010 May; 55(5):305-12. PubMed ID: 20482957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of Methylphenidate and Atomoxetine in Children with Attention-Deficit/Hyperactivity Disorder (ADHD): Data from the Italian National ADHD Registry.
    Cortese S; Panei P; Arcieri R; Germinario EA; Capuano A; Margari L; Chiarotti F; Curatolo P
    CNS Drugs; 2015; 29(10):865-77. PubMed ID: 26293742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The case of the missing methylphenidate.
    Diller L; Morrow R
    Pediatrics; 1997 Oct; 100(4):730-1. PubMed ID: 9333759
    [No Abstract]   [Full Text] [Related]  

  • 10. [Dualism of AD(H)D and the problem of surmounting it].
    Stümpfig S
    Kinderkrankenschwester; 2006 Oct; 25(10):400-5. PubMed ID: 17068900
    [No Abstract]   [Full Text] [Related]  

  • 11. The use of methylphenidate in Michigan.
    Kaufman G; Malone A
    Arch Pediatr Adolesc Med; 1996 May; 150(5):558-9. PubMed ID: 8620248
    [No Abstract]   [Full Text] [Related]  

  • 12. Methylphenidate and desipramine in hospitalized children: I. Separate and combined effects on cognitive function.
    Rapport MD; Carlson GA; Kelly KL; Pataki C
    J Am Acad Child Adolesc Psychiatry; 1993 Mar; 32(2):333-42. PubMed ID: 8444762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of methylphenidate in adults with attention deficit disorder with hyperactivity].
    Gauillard J; Castelnau C; Vacheron-Trystram MN; Cheref S; Caroli F
    Encephale; 1997; 23(4):251-6. PubMed ID: 9417389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysthymia and attention deficit disorder in adults.
    Mattes JA
    Am J Psychiatry; 1986 Jan; 143(1):114-5. PubMed ID: 3942264
    [No Abstract]   [Full Text] [Related]  

  • 15. Methylphenidate revisited.
    Med Lett Drugs Ther; 1988 May; 30(765):51-2. PubMed ID: 3362094
    [No Abstract]   [Full Text] [Related]  

  • 16. Central stimulants in the treatment of attention-deficit hyperactivity disorder (ADHD) in children and adolescents. A naturalistic study of the prescription in Sweden, 1977-2007.
    Janols LO; Liliemark J; Klintberg K; von Knorring AL
    Nord J Psychiatry; 2009 Nov; 63(6):508-16. PubMed ID: 19958258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylphenidate treatment and dyskinesia in children with attention-deficit/hyperactivity disorder.
    Balázs J; Dallos G; Keresztény A; Czobor P; Gádoros J
    J Child Adolesc Psychopharmacol; 2011 Apr; 21(2):133-8. PubMed ID: 21486166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.
    Epstein T; Patsopoulos NA; Weiser M
    Cochrane Database Syst Rev; 2014 Sep; (9):CD005041. PubMed ID: 25230710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zinc sulfate as an adjunct to methylphenidate for the treatment of attention deficit hyperactivity disorder in children: a double blind and randomized trial [ISRCTN64132371].
    Akhondzadeh S; Mohammadi MR; Khademi M
    BMC Psychiatry; 2004 Apr; 4():9. PubMed ID: 15070418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential Explanations for Increasing Methylphenidate Use in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder in Germany From 2004 to 2013.
    Langner I; Haug U; Scholle O; Lindemann C; Schröder C; Riedel O
    J Clin Psychopharmacol; 2019; 39(1):39-45. PubMed ID: 30489381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.